Hôpitaux Iris Sud Brussels, Belgium
Correspondence to: Bernard Hanson, MD, Hôpitaux Iris Sud (HIS), 142 Rue Marconi, Brussels B 1190, Belgium; e-mail: email@example.com
We read with interest the article in CHEST by Au et al (June 2003)1
on the risk of inhaled β-adrenoreceptor agonists in patients with left ventricular systolic dysfunction.
However, we were astonished not to see tobacco consumption among the recorded risk factors for death or degradation. Tobacco use remains the most preventable cause of death and disability in the United States.2
Far and away the most important cause of lung cancer is exposure to tobacco smoke through active or passive smoking.3–
It also is a leading cause of COPD. Tobacco smoking also has been involved in terms of the rate of cardiac death.4–
In 2000, Envangelista et al5
demonstrated, using a retrospective analysis of Veterans Affairs hospital records, that noncompliance with smoking restriction was a main risk factor for multiple hospital readmissions of patients with heart failure.
We would urge the authors of any study dealing with lung-related or heart-related morbidity or mortality to include tobacco usage as part of the variables assessed.
Become a CHEST member and receive a FREE subscription as a benefit of membership.
Individuals can purchase this article on ScienceDirect.
Individuals can purchase a subscription to the journal.
Individuals can purchase a subscription to the journal or buy individual articles.
Learn more about membership or Purchase a Full Subscription.
Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited:
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.